Abstract

Background: Human natural killer (NK) cells are key functional players in kidney transplant rejection. However, the respective contributions of the two functionally distinct human NK cell subsets (CD56bright cytokine-producing vs. CD56dim cytotoxic effector) in episodes of allograft rejection remain uncertain, with current immunohistochemical methods unable to differentiate these discrete populations. We report the outcomes of an innovative multi-color flow cytometric-based approach to unequivocally define and evaluate NK cell subsets in human kidney allograft rejection.Methods: We extracted renal lymphocytes from human kidney transplant biopsies. NK cell subsets were identified, enumerated, and phenotyped by multi-color flow cytometry. Dissociation supernatants were harvested and levels of soluble proteins were determined using a multiplex bead-based assay. Results were correlated with the histopathological patterns in biopsies—no rejection, borderline cellular rejection, T cell-mediated rejection (TCMR), and antibody-mediated rejection (AMR).Results: Absolute numbers of only CD56bright NK cells were significantly elevated in TCMR biopsies. In contrast, both CD56bright and CD56dim NK cell numbers were significantly increased in biopsies with histopathological evidence of AMR. Notably, expression of the activation marker CD69 was only significantly elevated on CD56dim NK cells in AMR biopsies compared with no rejection biopsies, indicative of a pathogenic phenotype for this cytotoxic NK cell subset. In line with this, we detected significantly elevated levels of cytotoxic effector molecules (perforin, granzyme A, and granulysin) in the dissociation supernatants of biopsies with a histopathological pattern of AMR.Conclusions: Our results indicate that human NK cell subsets are differentially recruited and activated during distinct types of rejection, suggestive of specialized functional roles.

Highlights

  • Kidney transplantation is the gold standard treatment for end stage kidney disease, with superior quality of life and patient survival compared to dialysis

  • Absolute numbers of only CD56bright natural killer (NK) cells were significantly elevated in T cell-mediated rejection (TCMR) biopsies

  • Expression of the activation marker CD69 was only significantly elevated on CD56dim NK cells in antibodymediated rejection (AMR) biopsies compared with no rejection biopsies, indicative of a pathogenic phenotype for this cytotoxic NK cell subset

Read more

Summary

Introduction

Kidney transplantation is the gold standard treatment for end stage kidney disease, with superior quality of life and patient survival compared to dialysis. Immunemediated allograft rejection is classified histopathologically into two types: T cell-mediated rejection (TCMR) and antibodymediated rejection (AMR) [2, 3]. Most immuno-biological studies of kidney allograft rejection have focused on conventional T (CD4+ or CD8+) and B cells. Less is known about the roles of innate lymphocytes in the different patterns of immune-mediated allograft rejection. Human natural killer (NK) cells are key functional players in kidney transplant rejection. The respective contributions of the two functionally distinct human NK cell subsets (CD56bright cytokine-producing vs CD56dim cytotoxic effector) in episodes of allograft rejection remain uncertain, with current immunohistochemical methods unable to differentiate these discrete populations. We report the outcomes of an innovative multi-color flow cytometric-based approach to unequivocally define and evaluate NK cell subsets in human kidney allograft rejection

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call